pre-miRNA Information
pre-miRNA hsa-mir-210   
Genomic Coordinates chr11: 568089 - 568198
Synonyms MIRN210, mir-210, MIR210
Description Homo sapiens miR-210 stem-loop
Comment This human miRNA was predicted by computational methods using conservation with mouse and Fugu rubripes sequences .
RNA Secondary Structure
Associated Diseases

Mature miRNA Information
Mature miRNA hsa-miR-210-3p
Sequence 66| CUGUGCGUGUGACAGCGGCUGA |87
Evidence Experimental
Experiments Cloned
Editing Events in miRNAs
Modification Type Position on miR Chromosome DNA Strand Genomic Position (hg38) List of PMIDs Variant details
A-to-I 12 11 - 568122 25582055 MiREDiBase
A-to-I 14 11 - 568120 26028588 MiREDiBase
C-to-U 1 11 - 568133 26209130 MiREDiBase
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs753825152 1 dbSNP
rs759616365 3 dbSNP
rs1247955373 6 dbSNP
rs558661304 9 dbSNP
rs1490451308 13 dbSNP
rs1344162213 14 dbSNP
rs745930382 15 dbSNP
rs1220183952 16 dbSNP
rs1355496181 17 dbSNP
rs1280245998 19 dbSNP
rs781628850 20 dbSNP
rs1241231800 22 dbSNP
Putative Targets

miRNA Expression profile
Human miRNA Tissue Atlas
miRNAs in Extracellular Vesicles
Circulating MicroRNA Expression Profiling
Biomarker Information
Biomarker ID Name Type Discovered From Mode Level Source Testing Methods
BX0CY6 miR-210 Predictive Biomarker (PRD); Safety Biomarker (SAF) Clinical/Experimental Data Expression Increase Urine Quantitative real-time reverse transcription PCR
BX0CY6 miR-210 Predictive Biomarker (PRD); Safety Biomarker (SAF) Clinical/Experimental Data Expression Low Blood Reverse transcription-polymerase chain reaction
Gene Information
Gene Symbol TFRC   
Synonyms CD71, IMD46, T9, TFR, TFR1, TR, TRFR, p90
Description transferrin receptor
Transcript NM_001128148   
Other Transcripts NM_003234   
Expression
Putative miRNA Targets on TFRC
3'UTR of TFRC
(miRNA target sites are highlighted)
>TFRC|NM_001128148|3'UTR
   1 ATGTGATACCCATAGCTTCCATGAGAACAGCAGGGTAGTCTGGTTTCTAGACTTGTGCTGATCGTGCTAAATTTTCAGTA
  81 GGGCTACAAAACCTGATGTTAAAATTCCATCCCATCATCTTGGTACTACTAGATGTCTTTAGGCAGCAGCTTTTAATACA
 161 GGGTAGATAACCTGTACTTCAAGTTAAAGTGAATAACCACTTAAAAAATGTCCATGATGGAATATTCCCCTATCTCTAGA
 241 ATTTTAAGTGCTTTGTAATGGGAACTGCCTCTTTCCTGTTGTTGTTAATGAAAATGTCAGAAACCAGTTATGTGAATGAT
 321 CTCTCTGAATCCTAAGGGCTGGTCTCTGCTGAAGGTTGTAAGTGGTCGCTTACTTTGAGTGATCCTCCAACTTCATTTGA
 401 TGCTAAATAGGAGATACCAGGTTGAAAGACCTTCTCCAAATGAGATCTAAGCCTTTCCATAAGGAATGTAGCTGGTTTCC
 481 TCATTCCTGAAAGAAACAGTTAACTTTCAGAAGAGATGGGCTTGTTTTCTTGCCAATGAGGTCTGAAATGGAGGTCCTTC
 561 TGCTGGATAAAATGAGGTTCAACTGTTGATTGCAGGAATAAGGCCTTAATATGTTAACCTCAGTGTCATTTATGAAAAGA
 641 GGGGACCAGAAGCCAAAGACTTAGTATATTTTCTTTTCCTCTGTCCCTTCCCCCATAAGCCTCCATTTAGTTCTTTGTTA
 721 TTTTTGTTTCTTCCAAAGCACATTGAAAGAGAACCAGTTTCAGGTGTTTAGTTGCAGACTCAGTTTGTCAGACTTTAAAG
 801 AATAATATGCTGCCAAATTTTGGCCAAAGTGTTAATCTTAGGGGAGAGCTTTCTGTCCTTTTGGCACTGAGATATTTATT
 881 GTTTATTTATCAGTGACAGAGTTCACTATAAATGGTGTTTTTTTAATAGAATATAATTATCGGAAGCAGTGCCTTCCATA
 961 ATTATGACAGTTATACTGTCGGTTTTTTTTAAATAAAAGCAGCATCTGCTAATAAAACCCAACAGATACTGGAAGTTTTG
1041 CATTTATGGTCAACACTTAAGGGTTTTAGAAAACAGCCGTCAGCCAAATGTAATTGAATAAAGTTGAAGCTAAGATTTAG
1121 AGATGAATTAAATTTAATTAGGGGTTGCTAAGAAGCGAGCACTGACCAGATAAGAATGCTGGTTTTCCTAAATGCAGTGA
1201 ATTGTGACCAAGTTATAAATCAATGTCACTTAAAGGCTGTGGTAGTACTCCTGCAAAATTTTATAGCTCAGTTTATCCAA
1281 GGTGTAACTCTAATTCCCATTTTGCAAAATTTCCAGTACCTTTGTCACAATCCTAACACATTATCGGGAGCAGTGTCTTC
1361 CATAATGTATAAAGAACAAGGTAGTTTTTACCTACCACAGTGTCTGTATCGGAGACAGTGATCTCCATATGTTACACTAA
1441 GGGTGTAAGTAATTATCGGGAACAGTGTTTCCCATAATTTTCTTCATGCAATGACATCTTCAAAGCTTGAAGATCGTTAG
1521 TATCTAACATGTATCCCAACTCCTATAATTCCCTATCTTTTAGTTTTAGTTGCAGAAACATTTTGTGGTCATTAAGCATT
1601 GGGTGGGTAAATTCAACCACTGTAAAATGAAATTACTACAAAATTTGAAATTTAGCTTGGGTTTTTGTTACCTTTATGGT
1681 TTCTCCAGGTCCTCTACTTAATGAGATAGTAGCATACATTTATAATGTTTGCTATTGACAAGTCATTTTAACTTTATCAC
1761 ATTATTTGCATGTTACCTCCTATAAACTTAGTGCGGACAAGTTTTAATCCAGAATTGACCTTTTGACTTAAAGCAGAGGG
1841 ACTTTGTATAGAAGGTTTGGGGGCTGTGGGGAAGGAGAGTCCCCTGAAGGTCTGACACGTCTGCCTACCCATTCGTGGTG
1921 ATCAATTAAATGTAGGTATGAATAAGTTCGAAGCTCCGTGAGTGAACCATCATTATAAACGTGATGATCAGCTGTTTGTC
2001 ATAGGGCAGTTGGAAACGGCCTCCTAGGGAAAAGTTCATAGGGTCTCTTCAGGTTCTTAGTGTCACTTACCTAGATTTAC
2081 AGCCTCACTTGAATGTGTCACTACTCACAGTCTCTTTAATCTTCAGTTTTATCTTTAATCTCCTCTTTTATCTTGGACTG
2161 ACATTTAGCGTAGCTAAGTGAAAAGGTCATAGCTGAGATTCCTGGTTCGGGTGTTACGCACACGTACTTAAATGAAAGCA
2241 TGTGGCATGTTCATCGTATAACACAATATGAATACAGGGCATGCATTTTGCAGCAGTGAGTCTCTTCAGAAAACCCTTTT
2321 CTACAGTTAGGGTTGAGTTACTTCCTATCAAGCCAGTACGTGCTAACAGGCTCAATATTCCTGAATGAAATATCAGACTA
2401 GTGACAAGCTCCTGGTCTTGAGATGTCTTCTCGTTAAGGAGATGGGCCTTTTGGAGGTAAAGGATAAAATGAATGAGTTC
2481 TGTCATGATTCACTATTCTAGAACTTGCATGACCTTTACTGTGTTAGCTCTTTGAATGTTCTTGAAATTTTAGACTTTCT
2561 TTGTAAACAAATGATATGTCCTTATCATTGTATAAAAGCTGTTATGTGCAACAGTGTGGAGATTCCTTGTCTGATTTAAT
2641 AAAATACTTAAACACTGAAAAAAAAAAA
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' agucGGCGACAGUGUGCGUGUc 5'
              | | |||  :||||||| 
Target 5' ggttCGGGTGT--TACGCACAc 3'
2204 - 2223 150.00 -17.40
2
miRNA  3' agucggcgACAGUG-UGCGUGUc 5'
                  |||||| || |||| 
Target 5' cttgaatgTGTCACTACTCACAg 3'
2088 - 2110 130.00 -17.20
3
miRNA  3' aguCGGCGACAGUGUGCGUGUc 5'
             |:: || ||  | ||||| 
Target 5' tttGTTTCT-TCCAAAGCACAt 3'
723 - 743 118.00 -6.20
DRVs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
COSN26998431 8 COSMIC
COSN20069177 9 COSMIC
COSN30490552 11 COSMIC
COSN30515544 50 COSMIC
COSN31549697 64 COSMIC
COSN30627810 66 COSMIC
COSN30467454 76 COSMIC
COSN31489453 116 COSMIC
COSN31511957 124 COSMIC
COSN30162697 127 COSMIC
COSN30160675 189 COSMIC
COSN26555607 212 COSMIC
COSN28757955 369 COSMIC
COSN31527895 493 COSMIC
COSN24299828 563 COSMIC
COSN30159338 574 COSMIC
COSN6760872 599 COSMIC
COSN31514211 713 COSMIC
COSN28647422 741 COSMIC
COSN31489095 761 COSMIC
COSN20984902 841 COSMIC
COSN25252249 859 COSMIC
COSN31532574 941 COSMIC
COSN32065332 951 COSMIC
COSN31596712 982 COSMIC
COSN31487037 1423 COSMIC
COSN1940073 1574 COSMIC
COSN31578601 1576 COSMIC
COSN16687269 1694 COSMIC
COSN31778343 1746 COSMIC
COSN32057651 2076 COSMIC
COSN8365486 2374 COSMIC
COSN22155954 2420 COSMIC
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs775817083 2 dbSNP
rs768055640 3 dbSNP
rs1233879597 4 dbSNP
rs759963198 6 dbSNP
rs1449118909 8 dbSNP
rs1482367682 9 dbSNP
rs774534222 10 dbSNP
rs761347442 12 dbSNP
rs1229158472 14 dbSNP
rs776156400 21 dbSNP
rs944293215 30 dbSNP
rs768148888 31 dbSNP
rs747005046 32 dbSNP
rs775418590 34 dbSNP
rs551249487 35 dbSNP
rs1368657966 37 dbSNP
rs1194978952 43 dbSNP
rs745706942 49 dbSNP
rs532965294 51 dbSNP
rs1255790362 56 dbSNP
rs753121387 63 dbSNP
rs142396803 64 dbSNP
rs983003380 69 dbSNP
rs952698412 72 dbSNP
rs746736298 76 dbSNP
rs1431097914 79 dbSNP
rs546731430 82 dbSNP
rs41298099 86 dbSNP
rs1473349657 89 dbSNP
rs1047782428 93 dbSNP
rs1421777580 96 dbSNP
rs958811270 117 dbSNP
rs758206388 127 dbSNP
rs1332294452 128 dbSNP
rs112002506 133 dbSNP
rs778941939 140 dbSNP
rs1394341508 141 dbSNP
rs1336133252 149 dbSNP
rs1340946209 167 dbSNP
rs1226444884 171 dbSNP
rs920647244 172 dbSNP
rs1319735398 174 dbSNP
rs1218931234 176 dbSNP
rs1377193165 180 dbSNP
rs1262101576 182 dbSNP
rs1037807593 183 dbSNP
rs1201633283 194 dbSNP
rs943491130 198 dbSNP
rs752694499 199 dbSNP
rs1332890276 214 dbSNP
rs1261563271 215 dbSNP
rs138410849 219 dbSNP
rs147024318 220 dbSNP
rs910726544 229 dbSNP
rs778879654 232 dbSNP
rs564018174 234 dbSNP
rs1296257659 238 dbSNP
rs892797306 239 dbSNP
rs1342201160 244 dbSNP
rs1400351442 245 dbSNP
rs1282280790 248 dbSNP
rs1310026857 262 dbSNP
rs1234803087 263 dbSNP
rs1256004495 275 dbSNP
rs370436322 277 dbSNP
rs1284475585 278 dbSNP
rs41298101 278 dbSNP
rs756326019 278 dbSNP
rs1361987805 281 dbSNP
rs913553156 287 dbSNP
rs753412262 290 dbSNP
rs996355590 294 dbSNP
rs1201092697 297 dbSNP
rs901572711 298 dbSNP
rs1040120723 307 dbSNP
rs545570605 311 dbSNP
rs1362339928 312 dbSNP
rs1032484580 318 dbSNP
rs1420105852 320 dbSNP
rs578236364 320 dbSNP
rs1388220030 327 dbSNP
rs887239474 336 dbSNP
rs1382420385 344 dbSNP
rs577759543 349 dbSNP
rs931578867 350 dbSNP
rs1307752775 352 dbSNP
rs191933212 355 dbSNP
rs1217821846 360 dbSNP
rs753958463 364 dbSNP
rs1013900921 367 dbSNP
rs991493947 368 dbSNP
rs1268282532 372 dbSNP
rs1439200346 383 dbSNP
rs1025577905 385 dbSNP
rs1382112796 386 dbSNP
rs1211990893 389 dbSNP
rs41298103 391 dbSNP
rs899164888 403 dbSNP
rs1260583084 408 dbSNP
rs556233718 417 dbSNP
rs1459228798 433 dbSNP
rs188960168 437 dbSNP
rs967195324 442 dbSNP
rs1020038087 444 dbSNP
rs889283028 447 dbSNP
rs1310734218 449 dbSNP
rs1051963429 450 dbSNP
rs555032802 452 dbSNP
rs990066773 456 dbSNP
rs957296270 459 dbSNP
rs1029098008 463 dbSNP
rs914127367 466 dbSNP
rs995871863 471 dbSNP
rs1301798546 472 dbSNP
rs1063480 473 dbSNP
rs1457438658 475 dbSNP
rs988371958 479 dbSNP
rs1240177082 482 dbSNP
rs750711783 493 dbSNP
rs1181257630 494 dbSNP
rs1382710217 501 dbSNP
rs1411493507 510 dbSNP
rs776820387 520 dbSNP
rs1425364192 521 dbSNP
rs901474941 536 dbSNP
rs1422485355 540 dbSNP
rs1463672326 543 dbSNP
rs1018712801 550 dbSNP
rs41298105 551 dbSNP
rs1302813231 557 dbSNP
rs1377563224 559 dbSNP
rs924981209 560 dbSNP
rs887311625 564 dbSNP
rs1294221346 565 dbSNP
rs1047252425 568 dbSNP
rs980926523 576 dbSNP
rs969189558 582 dbSNP
rs1025214570 583 dbSNP
rs1171824319 588 dbSNP
rs569805430 594 dbSNP
rs762167066 598 dbSNP
rs1235683442 603 dbSNP
rs991963105 605 dbSNP
rs1182235002 614 dbSNP
rs951209893 618 dbSNP
rs183985298 619 dbSNP
rs79872828 621 dbSNP
rs1016308842 622 dbSNP
rs1427050644 632 dbSNP
rs1357934295 634 dbSNP
rs576409185 634 dbSNP
rs1450904720 640 dbSNP
rs1314010636 641 dbSNP
rs1195082949 642 dbSNP
rs937373723 654 dbSNP
rs1280367478 663 dbSNP
rs750561451 663 dbSNP
rs928607720 664 dbSNP
rs981496381 666 dbSNP
rs1008041449 672 dbSNP
rs1276505676 673 dbSNP
rs1314014778 676 dbSNP
rs565574322 678 dbSNP
rs1211578526 679 dbSNP
rs1285190234 687 dbSNP
rs1487205644 693 dbSNP
rs774982002 695 dbSNP
rs760774303 699 dbSNP
rs1346705773 700 dbSNP
rs1477455264 701 dbSNP
rs1052295450 703 dbSNP
rs1426730965 704 dbSNP
rs1414523438 705 dbSNP
rs1174863038 710 dbSNP
rs767056696 720 dbSNP
rs1256161469 735 dbSNP
rs11541199 736 dbSNP
rs1418275667 738 dbSNP
rs1300373759 740 dbSNP
rs41298107 741 dbSNP
rs759097951 747 dbSNP
rs1369877519 753 dbSNP
rs989979696 763 dbSNP
rs1052604062 769 dbSNP
rs781422962 770 dbSNP
rs776307533 773 dbSNP
rs1218527589 778 dbSNP
rs770669857 785 dbSNP
rs371860311 787 dbSNP
rs957405837 788 dbSNP
rs1450806848 790 dbSNP
rs746681869 795 dbSNP
rs924922700 796 dbSNP
rs1454357533 797 dbSNP
rs534767092 801 dbSNP
rs1177415201 803 dbSNP
rs533738608 806 dbSNP
rs1438310379 808 dbSNP
rs1160965292 826 dbSNP
rs149850728 827 dbSNP
rs1405114045 845 dbSNP
rs1018618273 852 dbSNP
rs1434113445 855 dbSNP
rs917649966 860 dbSNP
rs1403197997 869 dbSNP
rs765735181 871 dbSNP
rs566572930 891 dbSNP
rs1372916817 896 dbSNP
rs367590607 897 dbSNP
rs1374761150 899 dbSNP
rs201074134 902 dbSNP
rs1242301729 912 dbSNP
rs1280044675 914 dbSNP
rs1171813653 918 dbSNP
rs950435863 922 dbSNP
rs1479126352 924 dbSNP
rs1255938719 925 dbSNP
rs1025842752 927 dbSNP
rs1468597011 932 dbSNP
rs1441282072 935 dbSNP
rs973985295 942 dbSNP
rs1201867287 944 dbSNP
rs1007731687 952 dbSNP
rs962682745 953 dbSNP
rs1184659578 964 dbSNP
rs898630838 965 dbSNP
rs1472691255 974 dbSNP
rs1161768366 980 dbSNP
rs41299364 982 dbSNP
rs1056060297 983 dbSNP
rs149105802 983 dbSNP
rs1002156665 984 dbSNP
rs577675212 990 dbSNP
rs1257253733 991 dbSNP
rs1170223022 1006 dbSNP
rs1219011610 1019 dbSNP
rs1240527949 1023 dbSNP
rs568873 1028 dbSNP
rs1329495355 1037 dbSNP
rs1339752716 1042 dbSNP
rs530936453 1051 dbSNP
rs946157594 1055 dbSNP
rs1319921080 1059 dbSNP
rs1285669792 1062 dbSNP
rs1335230639 1068 dbSNP
rs139807009 1075 dbSNP
rs1217697779 1078 dbSNP
rs1255731650 1079 dbSNP
rs1319433446 1082 dbSNP
rs1291299371 1087 dbSNP
rs1195826078 1089 dbSNP
rs913336567 1096 dbSNP
rs1007532320 1099 dbSNP
rs1442284957 1103 dbSNP
rs1054915875 1122 dbSNP
rs1186048311 1125 dbSNP
rs935854929 1127 dbSNP
rs551453168 1147 dbSNP
rs563823994 1156 dbSNP
rs1336221972 1157 dbSNP
rs1389947443 1167 dbSNP
rs1375764476 1168 dbSNP
rs1171835590 1169 dbSNP
rs965943464 1175 dbSNP
rs552141947 1193 dbSNP
rs41299366 1196 dbSNP
rs1168509433 1204 dbSNP
rs1463612560 1204 dbSNP
rs533549638 1219 dbSNP
rs1416361948 1228 dbSNP
rs1164778811 1232 dbSNP
rs1336075724 1238 dbSNP
rs1030334057 1243 dbSNP
rs997565526 1244 dbSNP
rs892628312 1250 dbSNP
rs1341932692 1254 dbSNP
rs191858782 1255 dbSNP
rs1254977505 1277 dbSNP
rs1189008635 1282 dbSNP
rs1435789452 1291 dbSNP
rs1001058921 1292 dbSNP
rs1486222269 1296 dbSNP
rs541663262 1297 dbSNP
rs1193337272 1298 dbSNP
rs1261319790 1316 dbSNP
rs911588623 1326 dbSNP
rs1458888978 1328 dbSNP
rs1194161019 1331 dbSNP
rs187555659 1333 dbSNP
rs1477066675 1343 dbSNP
rs1227721172 1345 dbSNP
rs1375944921 1354 dbSNP
rs1356947680 1362 dbSNP
rs1418888062 1366 dbSNP
rs950341234 1367 dbSNP
rs1296046571 1374 dbSNP
rs1386871283 1394 dbSNP
rs1382496309 1399 dbSNP
rs1300145696 1402 dbSNP
rs771889521 1404 dbSNP
rs1328891073 1407 dbSNP
rs1234732352 1410 dbSNP
rs1286095856 1416 dbSNP
rs1027419928 1417 dbSNP
rs1349159758 1418 dbSNP
rs1045745081 1419 dbSNP
rs561826784 1425 dbSNP
rs994963648 1427 dbSNP
rs947704703 1429 dbSNP
rs543049397 1438 dbSNP
rs1266899284 1442 dbSNP
rs1034930303 1443 dbSNP
rs1332236353 1448 dbSNP
rs1395623676 1450 dbSNP
rs929749367 1450 dbSNP
rs1365375418 1456 dbSNP
rs576031183 1465 dbSNP
rs1292617534 1471 dbSNP
rs907444999 1479 dbSNP
rs557616295 1491 dbSNP
rs1325630447 1496 dbSNP
rs1406523935 1503 dbSNP
rs962877420 1506 dbSNP
rs1190804218 1509 dbSNP
rs777106673 1510 dbSNP
rs1325911793 1514 dbSNP
rs1164502780 1515 dbSNP
rs1010203160 1519 dbSNP
rs1468106406 1529 dbSNP
rs1240133320 1535 dbSNP
rs911120211 1536 dbSNP
rs368558562 1545 dbSNP
rs141112537 1550 dbSNP
rs1030324261 1551 dbSNP
rs1487593516 1557 dbSNP
rs936081563 1568 dbSNP
rs1253771855 1573 dbSNP
rs1457356924 1576 dbSNP
rs1050254 1577 dbSNP
rs921821325 1578 dbSNP
rs1250970540 1579 dbSNP
rs1176749621 1588 dbSNP
rs1419480011 1591 dbSNP
rs1220551962 1593 dbSNP
rs1039265105 1595 dbSNP
rs17788379 1602 dbSNP
rs911832263 1608 dbSNP
rs1203487206 1621 dbSNP
rs983338482 1622 dbSNP
rs1462749339 1634 dbSNP
rs928963916 1639 dbSNP
rs920218029 1665 dbSNP
rs973219235 1671 dbSNP
rs959378547 1685 dbSNP
rs1034555177 1691 dbSNP
rs41299368 1702 dbSNP
rs1274706372 1704 dbSNP
rs1001017361 1705 dbSNP
rs1263695047 1706 dbSNP
rs971507972 1707 dbSNP
rs1024518036 1708 dbSNP
rs1063481 1710 dbSNP
rs904020753 1723 dbSNP
rs1010402707 1726 dbSNP
rs1316795887 1727 dbSNP
rs1398484898 1734 dbSNP
rs567606434 1735 dbSNP
rs1158709674 1738 dbSNP
rs41299370 1748 dbSNP
rs571809241 1755 dbSNP
rs891836123 1761 dbSNP
rs1033419111 1765 dbSNP
rs1190420827 1776 dbSNP
rs564248787 1778 dbSNP
rs1000313363 1780 dbSNP
rs900565666 1782 dbSNP
rs1190980707 1788 dbSNP
rs550234813 1794 dbSNP
rs749316392 1795 dbSNP
rs944536944 1799 dbSNP
rs780136725 1808 dbSNP
rs896149006 1809 dbSNP
rs406271 1837 dbSNP
rs1462999167 1842 dbSNP
rs1302758025 1843 dbSNP
rs561177538 1848 dbSNP
rs72547277 1850 dbSNP
rs552078948 1854 dbSNP
rs920309311 1855 dbSNP
rs1278113902 1856 dbSNP
rs1212886972 1862 dbSNP
rs941164998 1863 dbSNP
rs1308136521 1875 dbSNP
rs1220201067 1886 dbSNP
rs111271657 1898 dbSNP
rs750668342 1899 dbSNP
rs1268756852 1907 dbSNP
rs1262035059 1908 dbSNP
rs1476597538 1914 dbSNP
rs1187898584 1917 dbSNP
rs937666594 1918 dbSNP
rs1399982468 1925 dbSNP
rs1432062063 1927 dbSNP
rs1176016259 1939 dbSNP
rs1341675555 1946 dbSNP
rs560101628 1949 dbSNP
rs41299372 1950 dbSNP
rs976026021 1952 dbSNP
rs535950 1956 dbSNP
rs1428954635 1957 dbSNP
rs1272119557 1958 dbSNP
rs956723521 1964 dbSNP
rs529540414 1972 dbSNP
rs767686087 1976 dbSNP
rs757634632 1980 dbSNP
rs1234752558 1981 dbSNP
rs1285122803 1983 dbSNP
rs1445046323 1985 dbSNP
rs17091382 1986 dbSNP
rs1414649170 1989 dbSNP
rs1487886265 1992 dbSNP
rs968234348 1999 dbSNP
rs9842780 2004 dbSNP
rs575927561 2017 dbSNP
rs368013003 2018 dbSNP
rs522509 2023 dbSNP
rs1380126875 2028 dbSNP
rs1000623229 2038 dbSNP
rs900472010 2043 dbSNP
rs1320564645 2050 dbSNP
rs1263734010 2053 dbSNP
rs1435864098 2063 dbSNP
rs1017711091 2064 dbSNP
rs1008948145 2066 dbSNP
rs1373279571 2071 dbSNP
rs1235001006 2073 dbSNP
rs1308405548 2075 dbSNP
rs17091378 2076 dbSNP
rs114451457 2081 dbSNP
rs993445406 2084 dbSNP
rs896830139 2087 dbSNP
rs561395016 2100 dbSNP
rs1254401180 2101 dbSNP
rs139167593 2103 dbSNP
rs889625523 2119 dbSNP
rs1232765307 2130 dbSNP
rs1218330866 2134 dbSNP
rs1319231643 2136 dbSNP
rs1050050148 2150 dbSNP
rs1408990099 2150 dbSNP
rs1405057961 2156 dbSNP
rs765930681 2162 dbSNP
rs41299374 2169 dbSNP
rs1046169516 2170 dbSNP
rs1301725581 2176 dbSNP
rs1330618359 2182 dbSNP
rs41299376 2183 dbSNP
rs41299378 2187 dbSNP
rs1279994399 2189 dbSNP
rs1378158791 2197 dbSNP
rs988920036 2202 dbSNP
rs923974940 2203 dbSNP
rs956208545 2204 dbSNP
rs1329054706 2208 dbSNP
rs142135886 2209 dbSNP
rs41299380 2212 dbSNP
rs1424279112 2213 dbSNP
rs1436510175 2217 dbSNP
rs558147664 2217 dbSNP
rs17788373 2223 dbSNP
rs188924844 2224 dbSNP
rs747951436 2227 dbSNP
rs1413231356 2230 dbSNP
rs780111808 2232 dbSNP
rs371254267 2238 dbSNP
rs751895270 2238 dbSNP
rs991369301 2245 dbSNP
rs1169977152 2247 dbSNP
rs774153061 2252 dbSNP
rs1017616070 2255 dbSNP
rs143888949 2256 dbSNP
rs1329434183 2266 dbSNP
rs183406442 2269 dbSNP
rs954766025 2272 dbSNP
rs1484361443 2273 dbSNP
rs1231334453 2275 dbSNP
rs1198437505 2279 dbSNP
rs190451097 2280 dbSNP
rs550130791 2281 dbSNP
rs1412651588 2282 dbSNP
rs1458464029 2285 dbSNP
rs1260357756 2291 dbSNP
rs1232048110 2296 dbSNP
rs1217488446 2301 dbSNP
rs1409413577 2304 dbSNP
rs1267965820 2307 dbSNP
rs994429896 2314 dbSNP
rs1026177563 2315 dbSNP
rs1311469475 2320 dbSNP
rs35283966 2321 dbSNP
rs531402913 2323 dbSNP
rs1198129841 2331 dbSNP
rs1274277204 2338 dbSNP
rs898961736 2347 dbSNP
rs933420583 2349 dbSNP
rs1209102970 2352 dbSNP
rs563848253 2356 dbSNP
rs41299382 2359 dbSNP
rs1380910800 2367 dbSNP
rs1371461469 2370 dbSNP
rs1306573940 2372 dbSNP
rs889503573 2373 dbSNP
rs780047327 2375 dbSNP
rs186269975 2377 dbSNP
rs1400816368 2386 dbSNP
rs1049510545 2393 dbSNP
rs1374717736 2399 dbSNP
rs1002123107 2400 dbSNP
rs1456383904 2414 dbSNP
rs1375833194 2422 dbSNP
rs1399073456 2424 dbSNP
rs756201831 2432 dbSNP
rs1327721657 2433 dbSNP
rs560004372 2433 dbSNP
rs901020553 2434 dbSNP
rs1046032610 2435 dbSNP
rs764499080 2442 dbSNP
rs949161198 2442 dbSNP
rs780932269 2445 dbSNP
rs1282989556 2457 dbSNP
rs1052106168 2463 dbSNP
rs1486192908 2477 dbSNP
rs1204819186 2480 dbSNP
rs1178297779 2486 dbSNP
rs1448835846 2487 dbSNP
rs1044143851 2493 dbSNP
rs934833174 2495 dbSNP
rs1050153 2498 dbSNP
rs1452577697 2500 dbSNP
rs373017414 2512 dbSNP
rs1240476127 2514 dbSNP
rs1175424335 2518 dbSNP
rs41299384 2528 dbSNP
rs916630011 2529 dbSNP
rs1156469692 2554 dbSNP
rs979464476 2558 dbSNP
rs1386609267 2563 dbSNP
rs574522857 2568 dbSNP
rs960833413 2571 dbSNP
rs570 2573 dbSNP
rs190379777 2575 dbSNP
rs961648120 2577 dbSNP
rs1349092837 2580 dbSNP
rs1322961500 2582 dbSNP
rs1238716745 2583 dbSNP
rs987453572 2584 dbSNP
rs1353027739 2587 dbSNP
rs954671961 2588 dbSNP
rs1252512972 2592 dbSNP
rs576561991 2594 dbSNP
rs1467176391 2605 dbSNP
rs558333308 2605 dbSNP
rs1026407093 2615 dbSNP
rs1306417245 2627 dbSNP
rs1234493201 2638 dbSNP
rs993554635 2650 dbSNP
rs1253503319 2653 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
     
Conditions Jiyoye
Tools used in this research TargetScan
Original Description (Extracted from the article) ... HITS-CLIP data was present in Supplenentary. RNA binding protein: AGO2. ...

- Riley KJ; Rabinowitz GS; Yario TA; Luna JM; et al., 2012, The EMBO journal.

Article - Riley KJ; Rabinowitz GS; Yario TA; Luna JM; et al.
- The EMBO journal, 2012
Epstein-Barr virus (EBV) controls gene expression to transform human B cells and maintain viral latency. High-throughput sequencing and crosslinking immunoprecipitation (HITS-CLIP) identified mRNA targets of 44 EBV and 310 human microRNAs (miRNAs) in Jijoye (Latency III) EBV-transformed B cells. While 25% of total cellular miRNAs are viral, only three viral mRNAs, all latent transcripts, are targeted. Thus, miRNAs do not control the latent/lytic switch by targeting EBV lytic genes. Unexpectedly, 90% of the 1664 human 3'-untranslated regions targeted by the 12 most abundant EBV miRNAs are also targeted by human miRNAs via distinct binding sites. Half of these are targets of the oncogenic miR-17 approximately 92 miRNA cluster and associated families, including mRNAs that regulate transcription, apoptosis, Wnt signalling, and the cell cycle. Reporter assays confirmed the functionality of several EBV and miR-17 family miRNA-binding sites in EBV latent membrane protein 1 (LMP1), EBV BHRF1, and host CAPRIN2 mRNAs. Our extensive list of EBV and human miRNA targets implicates miRNAs in the control of EBV latency and illuminates viral miRNA function in general.
LinkOut: [PMID: 22473208]
Experimental Support 2 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
     
Conditions MCF 7 , MDA-MB-231
Location of target site 3'UTR
Original Description (Extracted from the article) ... These findings suggest that miR-210 works as an iron sensor and is involved in the maintenance of iron homeostasis by sustaining the TfR expression level to stimulate cell proliferation and promote cell survival in the hypoxic region within tumors. ...

- Yoshioka Y; Kosaka N; Ochiya T; Kato T, 2012, The Journal of biological chemistry.

miRNA-target interactions (Provided by authors)
ID Duplex structure Position
1
miRNA  3' agucGGCGACAGUGUGCGUGUc 5'
              | | |||  :||||||| 
Target 5' gguuCGGGUGU--UACGCACAc 3'
7 - 26
Article - Yoshioka Y; Kosaka N; Ochiya T; Kato T
- The Journal of biological chemistry, 2012
Iron is fundamental for sustaining life for living organisms, and the iron metabolism is finely regulated at different levels. In cancer cells, deregulation of the iron metabolism induces oxidative stress and drives tumor progression and metastasis; however, the molecular mechanisms of iron homeostasis are not fully understood. Here we found that iron deficiency as well as hypoxia promoted microRNA-210 (miR-210) expression. A central mediator of miR-210 transcriptional activation is the hypoxia-inducible factor (HIF)-1alpha, and the hypoxia-response element in the miR-210 promoter is confirmed experimentally. This is in agreement with the data from in vivo studies that have demonstrated the presence of miR-210-expressing cells at the chronic hypoxic regions of xenografted tumors. Furthermore we found two essential molecules for iron homeostasis, iron-sulfur cluster scaffold protein (ISCU) and transferrin receptor 1 (TfR), are a direct target of miR-210. Transfection of miR-210 decreases the uptake of transferrin by inhibiting the expression of TfR. In addition, inhibition of miR-210 by anti-miR-210 up-regulates ISCU expression. These findings suggest that miR-210 works as an iron sensor and is involved in the maintenance of iron homeostasis by sustaining the TfR expression level to stimulate cell proliferation and promote cell survival in the hypoxic region within tumors.
LinkOut: [PMID: 22896707]
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
STAD 0.537 0 0.453 0 32 Click to see details
KIRC -0.333 0 -0.270 0.01 68 Click to see details
BLCA 0.533 0.01 0.600 0 18 Click to see details
KICH 0.438 0.01 0.292 0.08 25 Click to see details
CESC 0.996 0.03 1.000 0.5 3 Click to see details
CHOL 0.602 0.04 0.617 0.04 9 Click to see details
PAAD 0.907 0.05 1.000 0.5 4 Click to see details
LIHC 0.242 0.05 0.236 0.05 49 Click to see details
BRCA 0.166 0.07 0.160 0.07 84 Click to see details
COAD -0.536 0.09 -0.690 0.03 8 Click to see details
KIRP 0.221 0.11 0.119 0.26 32 Click to see details
PRAD -0.151 0.15 -0.174 0.11 50 Click to see details
LUAD 0.259 0.21 0.455 0.07 12 Click to see details
HNSC 0.108 0.25 0.060 0.35 42 Click to see details
UCEC 0.152 0.27 0.126 0.3 19 Click to see details
THCA -0.072 0.29 -0.106 0.21 59 Click to see details
ESCA -0.162 0.32 -0.136 0.35 11 Click to see details
LUSC 0.053 0.38 -0.014 0.47 38 Click to see details
PCPG -0.345 0.39 0.500 0.33 3 Click to see details
PCPG -0.345 0.39 0.500 0.33 3 Click to see details
PCPG -0.345 0.39 0.500 0.33 3 Click to see details
126 hsa-miR-210-3p Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT000149 HOXA9 homeobox A9 4 1
MIRT000150 TP53I11 tumor protein p53 inducible protein 11 2 1
MIRT000151 PIM1 Pim-1 proto-oncogene, serine/threonine kinase 2 1
MIRT000152 HOXA1 homeobox A1 2 1
MIRT000153 FGFRL1 fibroblast growth factor receptor like 1 6 3
MIRT000156 RAD52 RAD52 homolog, DNA repair protein 5 3
MIRT001930 NPTX1 neuronal pentraxin 1 3 2
MIRT002024 EFNA3 ephrin A3 8 8
MIRT003153 BDNF brain derived neurotrophic factor 5 1
MIRT003154 PTPN1 protein tyrosine phosphatase, non-receptor type 1 5 1
MIRT003155 P4HB prolyl 4-hydroxylase subunit beta 6 2
MIRT003156 UBQLN1 ubiquilin 1 3 1
MIRT003157 SERTAD2 SERTA domain containing 2 3 1
MIRT003158 SEH1L SEH1 like nucleoporin 3 1
MIRT003159 NCAM1 neural cell adhesion molecule 1 4 1
MIRT003160 MID1IP1 MID1 interacting protein 1 3 1
MIRT003161 MDGA1 MAM domain containing glycosylphosphatidylinositol anchor 1 3 1
MIRT003162 KIAA1161 myogenesis regulating glycosidase (putative) 3 1
MIRT003163 ISCU iron-sulfur cluster assembly enzyme 6 7
MIRT003164 HOXA3 homeobox A3 3 1
MIRT003165 GPD1L glycerol-3-phosphate dehydrogenase 1 like 7 2
MIRT003166 DENND6A DENN domain containing 6A 3 1
MIRT003167 CPEB2 cytoplasmic polyadenylation element binding protein 2 5 1
MIRT003168 CDK10 cyclin dependent kinase 10 3 1
MIRT003169 ABCB9 ATP binding cassette subfamily B member 9 3 1
MIRT003170 CBX1 chromobox 1 3 1
MIRT003171 XIST X inactive specific transcript (non-protein coding) 4 1
MIRT003172 TNPO1 transportin 1 3 1
MIRT003173 SMCHD1 structural maintenance of chromosomes flexible hinge domain containing 1 3 1
MIRT003174 PTAR1 protein prenyltransferase alpha subunit repeat containing 1 3 1
MIRT003175 NIPBL NIPBL, cohesin loading factor 3 1
MIRT003176 MIB1 mindbomb E3 ubiquitin protein ligase 1 3 1
MIRT003177 HECTD1 HECT domain E3 ubiquitin protein ligase 1 3 1
MIRT003178 ELK3 ELK3, ETS transcription factor 3 1
MIRT003179 DDAH1 dimethylarginine dimethylaminohydrolase 1 4 1
MIRT003180 CLASP2 cytoplasmic linker associated protein 2 3 1
MIRT003181 CHD9 chromodomain helicase DNA binding protein 9 3 1
MIRT003182 ATP11C ATPase phospholipid transporting 11C 3 1
MIRT003183 APC APC, WNT signaling pathway regulator 3 1
MIRT003184 E2F3 E2F transcription factor 3 7 5
MIRT003185 ACVR1B activin A receptor type 1B 2 1
MIRT003916 MRE11A MRE11 homolog, double strand break repair nuclease 2 1
MIRT003917 XPA XPA, DNA damage recognition and repair factor 2 1
MIRT004672 MNT MAX network transcriptional repressor 4 2
MIRT006326 AIFM3 apoptosis inducing factor, mitochondria associated 3 3 2
MIRT006519 CASP8AP2 caspase 8 associated protein 2 4 1
MIRT006663 VMP1 vacuole membrane protein 1 3 2
MIRT006830 TFRC transferrin receptor 3 2
MIRT047002 PFDN2 prefoldin subunit 2 1 1
MIRT047003 U2AF2 U2 small nuclear RNA auxiliary factor 2 1 1
MIRT047004 UBA1 ubiquitin like modifier activating enzyme 1 1 1
MIRT047005 ESPL1 extra spindle pole bodies like 1, separase 1 1
MIRT047006 ACTR1A ARP1 actin related protein 1 homolog A 1 1
MIRT047007 SCN1B sodium voltage-gated channel beta subunit 1 1 1
MIRT047008 RCC2 regulator of chromosome condensation 2 1 1
MIRT053179 HSD17B1 hydroxysteroid 17-beta dehydrogenase 1 2 1
MIRT054098 NDUFA4 NDUFA4, mitochondrial complex associated 4 2
MIRT054099 SDHD succinate dehydrogenase complex subunit D 6 4
MIRT054141 STMN1 stathmin 1 3 1
MIRT054142 DIMT1L DIM1 dimethyladenosine transferase 1 homolog 4 2
MIRT054186 ROD1 polypyrimidine tract binding protein 3 3 1
MIRT054203 ALDH5A1 aldehyde dehydrogenase 5 family member A1 4 1
MIRT054204 FOXN3 forkhead box N3 5 2
MIRT054205 MCM3 minichromosome maintenance complex component 3 4 1
MIRT054206 IGFBP3 insulin like growth factor binding protein 3 6 2
MIRT054207 COL4A2 collagen type IV alpha 2 chain 6 2
MIRT054208 INPP5A inositol polyphosphate-5-phosphatase A 4 1
MIRT054209 EHD2 EH domain containing 2 4 1
MIRT054210 SH3BGRL SH3 domain binding glutamate rich protein like 5 2
MIRT054248 PTPN2 protein tyrosine phosphatase, non-receptor type 2 3 1
MIRT054321 LDHA lactate dehydrogenase A 2 1
MIRT054324 LDHB lactate dehydrogenase B 2 1
MIRT054349 HIF1A hypoxia inducible factor 1 alpha subunit 5 2
MIRT054714 FOXP3 forkhead box P3 3 1
MIRT054794 HIF3A hypoxia inducible factor 3 alpha subunit 3 1
MIRT115688 MGRN1 mahogunin ring finger 1 2 3
MIRT170674 INSIG1 insulin induced gene 1 1 1
MIRT437785 BNIP3 BCL2 interacting protein 3 5 2
MIRT438739 KCMF1 potassium channel modulatory factor 1 1 1
MIRT439407 TNPO3 transportin 3 1 1
MIRT439629 SIPA1L3 signal induced proliferation associated 1 like 3 1 1
MIRT439632 SIN3A SIN3 transcription regulator family member A 1 1
MIRT439740 RPL22 ribosomal protein L22 1 1
MIRT439886 PSAP prosaposin 1 1
MIRT439918 PPP1R2 protein phosphatase 1 regulatory inhibitor subunit 2 1 1
MIRT439928 POU2AF1 POU class 2 associating factor 1 1 1
MIRT440033 ICMT isoprenylcysteine carboxyl methyltransferase 2 3
MIRT440255 MEF2D myocyte enhancer factor 2D 1 1
MIRT440491 HMGCS1 3-hydroxy-3-methylglutaryl-CoA synthase 1 2 3
MIRT440570 GIT2 GIT ArfGAP 2 1 1
MIRT440647 FCHSD2 FCH and double SH3 domains 2 1 1
MIRT440830 DEAF1 DEAF1, transcription factor 1 1
MIRT440866 CSNK1E casein kinase 1 epsilon 1 1
MIRT472232 NFIC nuclear factor I C 2 2
MIRT473190 MITF melanogenesis associated transcription factor 2 2
MIRT477856 DYRK2 dual specificity tyrosine phosphorylation regulated kinase 2 2 2
MIRT497528 ZNF607 zinc finger protein 607 2 2
MIRT509770 SERTM1 serine rich and transmembrane domain containing 1 2 6
MIRT524407 CNTNAP5 contactin associated protein like 5 2 4
MIRT535209 PKIA cAMP-dependent protein kinase inhibitor alpha 2 4
MIRT554511 RUNX1T1 RUNX1 translocation partner 1 2 4
MIRT558069 ESCO2 establishment of sister chromatid cohesion N-acetyltransferase 2 2 2
MIRT572273 KCNJ6 potassium voltage-gated channel subfamily J member 6 2 2
MIRT574255 DOCK7 dedicator of cytokinesis 7 2 4
MIRT575621 Foxn3 forkhead box N3 2 2
MIRT575742 Zfp618 zinc finger protein 618 1 1
MIRT609050 VAMP4 vesicle associated membrane protein 4 2 2
MIRT611143 TNRC6B trinucleotide repeat containing 6B 2 4
MIRT699226 SLCO3A1 solute carrier organic anion transporter family member 3A1 2 2
MIRT703060 GTDC1 glycosyltransferase like domain containing 1 2 2
MIRT716005 ASB11 ankyrin repeat and SOCS box containing 11 2 2
MIRT731682 BTK Bruton tyrosine kinase 3 1
MIRT733090 DLEU2L deleted in lymphocytic leukemia 2-like 3 0
MIRT733091 BRCA2 BRCA2, DNA repair associated 3 0
MIRT733156 ITGA5 integrin subunit alpha 5 1 0
MIRT733501 GATA1 GATA binding protein 1 3 0
MIRT733503 SMAD2 SMAD family member 2 3 0
MIRT733525 MIR210HG MIR210 host gene 2 0
MIRT733615 TGFBI transforming growth factor beta induced 2 0
MIRT734175 KRAS KRAS proto-oncogene, GTPase 2 0
MIRT734293 PTEN phosphatase and tensin homolog 1 0
MIRT734568 STAT6 signal transducer and activator of transcription 6 1 0
MIRT734966 ADAMTS6 ADAM metallopeptidase with thrombospondin type 1 motif 6 1 0
MIRT736294 ID2 inhibitor of DNA binding 2, HLH protein 1 0
MIRT737104 FABP4 fatty acid binding protein 4, adipocyte 3 0
MIRT756028 NTN4 netrin 4 3 1
miRNA-Drug Associations
miRNA Small Melocule FDA CID Detection Method Condition PMID Year Expression Pattern of miRNA
miR-210 Vincristine approved 5978 Quantitative real-time PCR Hep-2 cells 23780424 2013 up-regualted
miR-210 Lenalidomide approved 216326 Quantitative real-time PCR peripheral blood CD14+ monocytes 25287904 2014 down-regulated
miR-210 Arsenic trioxide approved 14888 Microarray lymphoblast cell line TK-6 17108120 2006 down-regulated
miR-210 5-Fluorouracil approved 3385 Quantitative real-time PCR colon cancer cells 17702597 2007 down-regulated
miR-210 Arsenic trioxide approved 14888 Microarray HepG-2 human hepatocellular carcinoma cell line 21175813 2011 up-regulated
miR-210 Arsenic trioxide approved 14888 Quantitative real-time PCR HepG-2 human hepatocellular carcinoma cell line 21175813 2011 up-regulated
miR-210 Arsenic trioxide approved 14888 Quantitative real-time PCR HepG-2 human hepatocellular carcinoma cell line 21175813 2011 up-regulated
miR-210 Ginsenoside Rh2 NULL 119307 Microarray human glioma cells U251 21372826 2011 down-regulated
miR-210 Aidi injection NULL NULL Microarray human breast cancer cells 21563499 2011 down-regulated
miR-210 5-aza-2'-deoxycytidine (5-Aza-CdR) approved 451668 Microarray breast cancer HB2 22076154 2011 down-regulated
miR-210 5-aza-2'-deoxycytidine (5-Aza-CdR) approved 451668 Microarray breast cancer MDA-MB231 22076154 2011 down-regulated
miR-210 5-aza-2'-deoxycytidine (5-Aza-CdR) approved 451668 Microarray breast cancer SKBR3 22076154 2011 down-regulated
miR-210 Trastuzumab approved NULL Microarray HER2-positive breast cancer 22384020 2012 down-regulated
miR-210 Trastuzumab approved NULL Quantitative real-time PCR HER2-positive breast cancer 22384020 2012 down-regulated
miR-210 Trastuzumab approved NULL Microarray BT474 cells 22384020 2012 down-regulated
miR-210 Curcumin NULL 969516 Quantitative real-time PCR Y79 RB cells. 22510010 2012 down-regulated
miR-210 Bicalutamide approved 2375 Microarray prostate 22674191 2012 down-regulated
miR-210 Goserelin approved 47725 Microarray prostate 22674191 2012 down-regulated
miR-210 Olea europaea leaf extract NULL NULL Quantitative real-time PCR glioblastoma cells. 22722712 2012 up-regulated
miR-210 Temozolomide approved 5394 Quantitative real-time PCR glioblastoma cells. 22722712 2012 up-regulated
miR-210 Nicotine approved 89594 Microarray Rat adrenal pheochromocytoma PC12 cell 18845019 2009 down-regulated
miR-210 Comfrey NULL 6440495 Microarray rat liver 21370286 2011 up-regulated
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-mir-210 Cisplatin 5460033 NSC119875 approved resistant High Gastric Cancer cell line (BGC823)
hsa-mir-210 Ceritinib 57379345 NSC776422 approved resistant High Non-Small Cell Lung Cancer cell line (H3122, H2228)
hsa-mir-210 Dabrafenib 44462760 NSC764134 approved resistant cell line (A375)
hsa-mir-210 Paclitaxel 36314 NSC125973 approved resistant cell line (W1)
hsa-mir-210 Androstenedione 6128 NSC9563 sensitive cell line (MCF-7)
hsa-mir-210 Androstenedione+Letrozole sensitive cell line (MCF-7)
hsa-mir-210 Tamoxifen 2733525 NSC180973 approved resistant tissue (ER-positive breast cancer)
hsa-mir-210 Fluorouracil 3385 NSC19893 approved sensitive cell line (OE19)
hsa-mir-210 Ceritinib 57379345 NSC776422 approved resistant cell line (H3122)
hsa-mir-210 Cisplatin 5460033 NSC119875 approved resistant cell line (BGC-823)
hsa-miR-210-3p (E)-1-[3,5-bis[(dimethylamino)methyl]-4-hydroxyphenyl]-3-phenylprop-2-en-1-one 6374691 NSC677784 resistant
hsa-miR-210-3p (e)-3-chloro-3-(4-methoxyphenyl)-2-(4-nitrophenyl)prop-2-enal 5387396 NSC623175 resistant
hsa-miR-210-3p [(E)-(1-chloro-2-methylpropylidene)amino] N-anilinocarbamate 5494354 NSC682841 resistant
hsa-miR-210-3p [(E)-1-chloropropylideneamino] N-[2-(trifluoromethoxy)phenyl]carbamate 5466266 NSC682836 resistant
hsa-miR-210-3p [2-[(e)-(carbamothioylhydrazono)methyl]-6-methoxy-phenoxy]-hydroxy-copper; 2-(2-pyridyl)pyridine 135484845 NSC638302 resistant
hsa-miR-210-3p 1-(4-ethoxyphenyl)-3-(2-methyl-5-propan-2-ylphenyl)urea 240168 NSC46213 sensitive
hsa-miR-210-3p 1-(4-nitrophenyl)-3-(2-pyridyl)thiourea 3005383 NSC695329 sensitive
hsa-miR-210-3p 1-(naphthalen-1-ylmethyl)-4-[1-(naphthalen-1-ylmethyl)piperidin-4-yl]piperidine 364095 NSC669995 resistant
hsa-miR-210-3p 1-[2-(4-nitrophenyl)-2-oxoethyl]-4-pentylpyridin-1-ium bromide 24181037 NSC4290 resistant
hsa-miR-210-3p 11-(3-methoxyphenyl)-2,12,15-triazapentacyclo[11.7.1.03,8.09,21.014,19]henicosa-1,3,5,7,9,11,13(21),14(19),15,17-decaen-20-one 54608964 NSC697747 resistant
hsa-miR-210-3p 17-acetyl-9,14-dihydroxy-16-methyl-15-(4-methylphenyl)-15-azatetracyclo[8.7.0.01,14.03,8]heptadeca-3,5,7,9,12,16-hexaene-2,11-dione 405612 NSC722982 resistant
hsa-miR-210-3p 1h-benz[g]indol-5-ol, 2-phenyl 371327 NSC645431 resistant
hsa-miR-210-3p 2-[[4-anilino-5-[8-[4-anilino-5-[(1-hydroxynaphthalen-2-yl)oxymethyl]-1,2,4-triazol-3-yl]octyl]-1,2,4-triazol-3-yl]methoxy]naphthalen-1-ol 394049 NSC697167 resistant
hsa-miR-210-3p 2-[9-[(7-oxocyclohepta-1,3,5-trien-1-yl)amino]nonylamino]cyclohepta-2,4,6-trien-1-one 358331 NSC618296 resistant
hsa-miR-210-3p 2-amino-5,8-dihydroxy-1,4-naphthoquinone 377209 NSC658441 resistant
hsa-miR-210-3p 2-bromo-4-(5-fluoro-1,3-benzothiazol-2-yl)aniline 399248 NSC709925 sensitive
hsa-miR-210-3p 2-hydroxy-5-({(e)-[(10-hydroxyacridin-9(10h)-ylidene)methyl]diazenyl}sulfonyl)benzoic acid 363212 NSC627890 resistant
hsa-miR-210-3p 3'-chloro-3-nitro-o-salicylotoluidide 332278 NSC328477 resistant
hsa-miR-210-3p 3-((4-(methylthio)phenoxy)methyl)-2-oxiranol 366923 NSC636087 resistant
hsa-miR-210-3p 4-(2-phenylethylamino)naphthalene-1,2-dione 367789 NSC637731 resistant
hsa-miR-210-3p 4-[(E)-2-piperidin-1-ylethenyl]benzo[g]quinoline-5,10-dione 5781544 NSC642968 resistant
hsa-miR-210-3p 4-[(r)-[(2s,5r)-2,5-dimethyl-4-prop-2-enylpiperazin-1-yl]-(3-methoxyphenyl)methyl]-n-pentan-3-ylbenzamide;hydrochloride 5471112 NSC708822 resistant
hsa-miR-210-3p 4-[2-(methylamino)-1-methylsulfanylethyl]benzene-1,2-diol 412349 NSC39215 resistant
hsa-miR-210-3p 4-[4-(4-sulfinobutyldisulfanyl)butyldisulfanyl]butane-1-sulfinic acid 361262 NSC624205 resistant
hsa-miR-210-3p 4-acetamido-n-[(e)-(2,4-dichlorophenyl)methylideneamino]-2-methoxybenzamide 9572428 NSC716142 sensitive
hsa-miR-210-3p 4-aminodithiolane-4-carboxylic acid 269217 NSC109825 resistant
hsa-miR-210-3p 4-hydroxy-3-[1-(1-hydroxy-3,4-dioxonaphthalen-2-yl)-3-phenylpropyl]naphthalene-1,2-dione 272651 NSC117274 resistant
hsa-miR-210-3p 4,4-dimethylspiro[1,3,2-oxazaphospholidin-2-ium-2,2'-3h-1,3,2-benzoxazaphosphol-2-ium]-5-one 6330525 NSC351866 resistant
hsa-miR-210-3p 4b-hydroxy-10,10-dimethoxy-9ah-indeno[1,2-a]inden-9-one 363252 NSC628000 resistant
hsa-miR-210-3p 4h,7h-furo[2',3',4':4,5]naphth[2,1-e][1,3]oxazin-4-one, 8-(4-chlorophenyl)-8,9-dihydro- 373969 NSC651001 resistant
hsa-miR-210-3p 5,6,7-trimethoxy-N-(4H-pyrazolo[1,5-a]indol-2-yl)-1H-indole-2-carboxamide 404173 NSC720326 resistant
hsa-miR-210-3p 6-(3-chloropropyl)-3-nitroindeno[1,2-c]isoquinoline-5,11-dione 17755848 NSC731154 resistant
hsa-miR-210-3p 6-benzyloxyhexanal 389877 NSC686505 resistant
hsa-miR-210-3p 7-[(E)-2-(1,6-dimethylquinolin-1-ium-2-yl)ethenyl]-5-methylquinolin-8-ol 135483953 NSC86371 resistant
hsa-miR-210-3p 7-[(naphthalen-1-ylamino)(phenyl)methyl]quinolin-8-ol 256754 NSC84092 resistant
hsa-miR-210-3p 7-chloro-6-n-(2-fluoroethylamino)-5,8-quinolinedione 379079 NSC663286 resistant
hsa-miR-210-3p 7-o,8-o-isopropylidene iriomoteolide 3a 24808220 NSC753164 resistant
hsa-miR-210-3p 9h-quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-phenyl- 4567749 NSC686553 resistant
hsa-miR-210-3p Acetyltrophanthidin 261075 NSC92954 resistant
hsa-miR-210-3p Adenosine, 2-bromo-2'-deoxy- 334838 NSC341936 resistant
hsa-miR-210-3p Asimicinone 393461 NSC695394 resistant
hsa-miR-210-3p Benzo[b]naphtho[2,3-d]furan-6,11-dione, 4-chloro-3-hydroxy 371025 NSC644902 resistant
hsa-miR-210-3p Benzo[g]pteridine-2,4(3h,10h)-dione, 10-(2,4-dimethylphenyl)-3-methyl- 363228 NSC627974 resistant
hsa-miR-210-3p Benzo[g]pteridine-2,4(3h,10h)-dione, 10-(4-chlorophenyl)-3,7,8-trimethyl- 363246 NSC627992 resistant
hsa-miR-210-3p Benzo[g]pteridine-2,4(3h,10h)-dione, 3-methyl-10-[3-(methylthio)phenyl]- 363242 NSC627988 resistant
hsa-miR-210-3p Benzo[g]quinoxaline-5,10-dione, 5,10-dihydro-2,3-dimethyl- 353644 NSC602617 resistant
hsa-miR-210-3p Celcot rm 67277 NSC37168 resistant
hsa-miR-210-3p Cytarabine 6253 NSC287459 approved resistant
hsa-miR-210-3p Destruxin a 122810 NSC361126 resistant
hsa-miR-210-3p Di-p-tolyliodinium bromide 54601177 NSC8985 resistant
hsa-miR-210-3p Diethoxybis(1,4-naphthochinone-2-olato)titanium(iv) 368297 NSC638842 resistant
hsa-miR-210-3p Dihydrorotenone 243725 NSC53866 resistant
hsa-miR-210-3p Diisopropoxybis(1,4-naphthochinone-2-olato)titanium(iv) 368058 NSC638383 resistant
hsa-miR-210-3p Discorhabdin i 135409047 NSC656206 resistant
hsa-miR-210-3p Dpbq 364074 NSC629713 resistant
hsa-miR-210-3p Ethyl 6-chloro-4-phenyl-2-(piperazin-1-ylmethyl)quinoline-3-carboxylate 369623 NSC641536 resistant
hsa-miR-210-3p Ethyl 6-hydroxy-4-(4-methoxyphenyl)-6-methyl-3-oxo-2-phenyl-1,4,5,7-tetrahydroindazole-5-carboxylate 392845 NSC693857 resistant
hsa-miR-210-3p Gnmlngdfmleynr-uhfffaoysa-n 402862 NSC717147 sensitive
hsa-miR-210-3p Gw612286x 9822610 NSC756278 sensitive
hsa-miR-210-3p Gw811761x 6539382 NSC756375 sensitive
hsa-miR-210-3p Herbimycin 6436247 NSC305978 resistant
hsa-miR-210-3p Hypothemycin 5458809 NSC354462 resistant
hsa-miR-210-3p Indole-2,3-dione, 5-methyl-, 3-[(o-nitrophenyl)hydrazone] 3632950 NSC117915 sensitive
hsa-miR-210-3p J3.572.907k 396709 NSC703318 resistant
hsa-miR-210-3p Methyl 10-acetyl-3-(4-methylphenyl)sulfonyl-9-(2-methylprop-1-enyl)-3,10-diazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13),11-pentaene-11-carboxylate NSC621968 resistant
hsa-miR-210-3p Methyl 8-[(4-chlorophenyl)carbamoyl]naphthalene-1-carboxylate 364289 NSC630307 resistant
hsa-miR-210-3p N-(2-morpholin-4-ylethyl)-5-nitroquinolin-4-amine;hydrochloride 372042 NSC646859 resistant
hsa-miR-210-3p N-(3-chloro-1,4-dioxonaphthalen-2-yl)-4-naphthalen-2-yl-2,4-dioxo-3-(3-oxo-1H-2-benzofuran-1-yl)butanamide 369463 NSC641233 resistant
hsa-miR-210-3p N-(3,5-dicyano-2-(4-methylphenyl)-6-oxo-4-phenyl-1(6h)-pyridinyl)-4-methylbenzenesulfonamide 390286 NSC687578 resistant
hsa-miR-210-3p N-[(1E)-1-(1-hydroxypyridin-2-ylidene)ethyl]iminoazepane-1-carbothioamide 5369124 NSC351075 resistant
hsa-miR-210-3p N-[1,1,1,3,3,3-hexafluoro-2-(4-fluoroanilino)propan-2-yl]butanamide 389152 NSC684836 resistant
hsa-miR-210-3p Naphtho[2,3-d]-1,3-dioxepin-6,11-dione, 4-methyl- NSC626868 resistant
hsa-miR-210-3p Naphtho[2,3-d]oxazole-4,9-dione, 2-(1,1-dimethylethyl)- 370622 NSC643915 resistant
hsa-miR-210-3p Niosh/br9826000 359483 NSC620462 resistant
hsa-miR-210-3p NSC619321 NSC619321 sensitive
hsa-miR-210-3p NSC621321 NSC621321 resistant
hsa-miR-210-3p NSC631451 NSC631451 resistant
hsa-miR-210-3p NSC634766 NSC634766 resistant
hsa-miR-210-3p NSC635414 NSC635414 resistant
hsa-miR-210-3p Pentyl 6-(chloromethyl)-2-oxo-2h-chromene-3-carboxylate 402498 NSC716524 resistant
hsa-miR-210-3p Pmp (van) 72508 NSC1906 resistant
hsa-miR-210-3p Scillirosidin, glycoside 222160 NSC7534 resistant
hsa-miR-210-3p Sesbanimide 163490 NSC355461 resistant
hsa-miR-210-3p Snc 80 123924 NSC707484 resistant
hsa-miR-210-3p Streptovaricin b 135443622 NSC156215 resistant
hsa-miR-210-3p Tetratert-butyl 8,11-dimethoxytricyclo[4.3.3.01,6]dodeca-7,10-diene-7,9,10,12-tetracarboxylate 362411 NSC626176 resistant
hsa-miR-210-3p Tolonium chloride 7083 NSC36758 resistant
hsa-miR-210-3p Z48861686 4784054 NSC745813 resistant
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant High Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive High Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Temozolomide 5394 NSC362856 approved resistant High Glioblastoma cell line (U251MG, U251R, U87MG, M059K, M059J)
hsa-miR-210-3p Imatinib 5291 NSC743414 approved resistant High Myelogenous Leukemia cell line (MYL)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colon Cancer cell line (HT-29)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colon Cancer cell line (HT-29)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant High Ehrlich Ascites Tumor cell line (EHR2,P6, P12, P36, P72, EHR2/1.3)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant High Ehrlich Ascites Tumor cell line (EHR2,P6, P12, P36, P72, EHR2/1.3)
hsa-miR-210-3p Trastuzumab resistant Low Breast Cancer tissue and cell line (BT-474, BTR65)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Vincristine 5978 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant Low Cervical Cancer tissue and cell line (SiHa, Cask)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant High Laryngeal Cancer cell line (Hep2)
hsa-miR-210-3p Fluorouracil + Oxaliplatin resistant High Colorectal Cancer tissue
hsa-miR-210-3p Docetaxel 148124 NSC628503 approved resistant High Prostate Cancer cell line (DU-145)
hsa-miR-210-3p Asparaginate 5460875 sensitive Low Pediatric Acute Lymphoblastic Leukemia Reh cells
hsa-miR-210-3p Dexamethasone 5743 NSC34521 approved sensitive Low Pediatric Acute Lymphoblastic Leukemia Reh cells
hsa-miR-210-3p Daunorubicin 30323 NSC82151 approved sensitive Low Pediatric Acute Lymphoblastic Leukemia Reh cells
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant High Pancreatic Cancer cell line (PANC-1)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved resistant High Pancreatic Cancer cell line (PANC-1)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved sensitive High Esophageal Adenocarcinoma cell line (OE19)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant High Hepatocellular Carcinoma tissue and cell line (HepG2)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive High Pancreatic Cancer cell line (SW1990)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant High Pancreatic Cancer cell line (SW1990)
hsa-miR-210-3p Taxane 9548828 sensitive High Prostate Cancer cell line (PC-3, PR20)
hsa-miR-210-3p Taxane 9548828 sensitive High Prostate Cancer cell line (PC-3, PR70)
hsa-miR-210-3p Dexamethasone 5743 NSC34521 approved sensitive High Myeloma cell line (MM1R, MM1S)
hsa-miR-210-3p Platinum 23939 sensitive High Ovarian Cancer tissue
hsa-miR-210-3p Daunorubicin 30323 NSC82151 approved sensitive High Acute Myeloid Leukemia cell line (U-937, KG-1)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Pancreatic Ductal Adenocarcinoma cell line (MIA-PaCa-2)
hsa-miR-210-3p Trametinib 11707110 NSC758246 approved sensitive Low Melanoma cell line (MML-1)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant High Ovarian Cancer cell line (SKOV3)
hsa-miR-210-3p Tamoxifen 2733525 NSC180973 approved resistant Low Breast Cancer cell line (TAMR4, TAMR8)
hsa-miR-210-3p Aromatase Inhibitor sensitive Low Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Epirubicin 41867 NSC256942 approved resistant High Breast Cancer cell line (MDA-MB-231)
hsa-miR-210-3p Docetaxel 148124 NSC628503 approved resistant High Breast Cancer cell line (MDA-MB-231)
hsa-miR-210-3p Vinorelbine 44424639 approved resistant High Breast Cancer cell line (MDA-MB-231)
hsa-miR-210-3p 1'-Acetoxychavicol acetate 119104 NSC711510 resistant Low Cervical Cancer cell line (Ca Ski, SiHa)
hsa-miR-210-3p Dabrafenib 44462760 NSC764134 approved sensitive High Melanoma cell line (A375, IGR37, 501Mel)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive High Melanoma cell line (A375, IGR37, 501Mel)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive High Non-Small Cell Lung Cancer cell line (A549)
hsa-miR-210-3p Imatinib 5291 NSC743414 approved sensitive High Chronic Myelogenous Leukemia cell line (K562)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive Low Renal Cell Cancer cell line (Caki-2)
hsa-miR-210-3p Vinblastine 442111 NSC90636 approved sensitive Low Renal Cell Cancer cell line (Caki-2)
hsa-miR-210-3p Fulvestrant 17756771 NSC719276 approved resistant High Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Ceritinib 57379345 NSC776422 approved resistant High Non-Small Cell Lung Cancer cell line (H3122, H2228)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colorectal Cancer cell line (LS174T)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Cholangiocarcinoma cell line (KKU-213, KKU-055, KKU-100)
hsa-miR-210-3p Docetaxel 148124 NSC628503 approved resistant Low Breast Cancer tissue
hsa-miR-210-3p Palbociclib 5330286 NSC758247 approved sensitive High Breast Cancer cell line (T47D)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive High Ovarian Cancer cell line (SKOV3)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive Low Ovarian Cancer cell line (SKOV3)
hsa-miR-210-3p Cetuximab + Folfox(Fluorouracil + Leucovorin + Oxaliplatin) sensitive High Metastatic Colorectal Cancer tissue
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved sensitive Low Colorectal Cancer cell line (HT-29)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Pancreatic Cancer cell line (BXPC-3)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colorectal Adenocarcinoma cell line (HT-29)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Pancreatic Cancer cell line (PANC-1)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant Low Oral Cancer cell line (SAS, HSC-3, HSC-4)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive High Endometrial Serous Carcinoma cell line (USPC1)
hsa-miR-210-3p Imatinib 5291 NSC743414 approved sensitive Low Chronic Myelogenous Leukemia tissue
hsa-miR-210-3p Dabrafenib 44462760 NSC764134 approved resistant High Melanoma cell line (A375)
hsa-miR-210-3p Sunitinib 5329102 NSC750690 approved resistant Low Renal Cell Cancer tissue
hsa-miR-210-3p Temozolomide 5394 NSC362856 approved resistant Low Glioma cell line (U87)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive High Hypopharyngeal Cancer cell line (FaDu)
hsa-miR-210-3p Platinum 23939 resistant High High-Grade Serous Ovarian Cancer tissue
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive Low Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Sorafenib 216239 NSC747971 approved resistant High Hepatocellular Carcinoma cell line (PLC/PRF5-R1, PLC/PRF5-R2, PLC/PRF5)
hsa-miR-210-3p Gefitinib 123631 NSC715055 approved sensitive cell line (HCC827)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (A375)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (CAL-27) (total RNA)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (CAL-27) (mitochondrial RNA)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (451Lu)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant cell line (SKVO3ip1)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (HeyA8)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (LM17)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM16)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (LM11)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM43)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM47)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive cell line (HS578T)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant cell line (BAS)
hsa-miR-210-3p Tamoxifen+Fulvestrant sensitive cell line (LCC9)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line (CIS)
hsa-miR-210-3p Exemestane 60198 NSC713563 approved resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone 6013 NSC9700 approved resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Exemestane resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Letrozole resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Anastrozole resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Tamoxifen resistant cell line (MCF-7)
hsa-miR-210-3p Osimertinib 71496458 NSC779217 approved sensitive cell line (H1975)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant cell line (HT29)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved resistant cell line (KM12C) (72 h)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line (RPMI2650)
hsa-miR-210-3p Sunitinib 5329102 NSC750690 approved resistant tissue (CardA)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant cell line (SKOV3)
hsa-miR-210-3p Platinum 23939 resistant tissue (non-small cell lung cancer)
hsa-miR-210-3p Tamoxifen 2733525 NSC180973 approved resistant cell line (TamR4)
hsa-miR-210-3p Tamoxifen 2733525 NSC180973 approved resistant cell line (TamR8)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (PC3PR20)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (PC3PR200)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (PC3PR70)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM16)
hsa-miR-210-3p Bortezomib 387447 NSC681239 approved sensitive cell line (CCRF-CEM) (100 nM)
hsa-miR-210-3p Bortezomib 387447 NSC681239 approved sensitive cell line (CCRF-CEM) (200 nM)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive cell line (PANC-1) (100 ng/ml)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive cell line (PANC-1) (1500 ng/ml)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive cell line (Panc1-GR1)
hsa-miR-210-3p Ceritinib 57379345 NSC776422 approved resistant cell line (H3122)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line (H23)
hsa-miR-210-3p Cetuximab sensitive tissue (colorectal carcinoma)

Error report submission